Prometheus Life Technologies was awarded second prize at the Bio in Space Innovation Challenge, held as part of TechConnect World 2026 in Raleigh, North Carolina.
The challenge brought together innovative companies developing technologies that leverage space and microgravity to advance biotechnology, human health and regenerative medicine.
Prometheus presented its vision for using human organoids produced in microgravity to advance liver regeneration and develop new therapeutic applications. The recognition highlights the potential of space-based biomanufacturing to contribute to future advances in biomedical research and regenerative medicine.
We are proud to have been recognised alongside other innovators helping shape the future of biotechnology in space.